InvestorsHub Logo
Followers 7
Posts 564
Boards Moderated 0
Alias Born 08/27/2014

Re: massulo52 post# 164989

Tuesday, 12/04/2018 9:44:06 AM

Tuesday, December 04, 2018 9:44:06 AM

Post# of 425931
The key issue is whether or not payers will readily cover Vascepa as an add-on to statin therapy prior to a formal approval from U.S. regulators. Why are you stalling JT?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News